RAMM Stock Overview
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
RAMM Pharma Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.065 |
| 52 Week High | CA$0.12 |
| 52 Week Low | CA$0.015 |
| Beta | -0.40 |
| 1 Month Change | 116.67% |
| 3 Month Change | 44.44% |
| 1 Year Change | 8.33% |
| 3 Year Change | -93.16% |
| 5 Year Change | n/a |
| Change since IPO | -90.15% |
Recent News & Updates
Shareholder Returns
| RAMM | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 8.3% | -3.6% | -2.1% |
| 1Y | 8.3% | 58.0% | 3.6% |
Return vs Industry: RAMM underperformed the Canadian Pharmaceuticals industry which returned 58% over the past year.
Return vs Market: RAMM exceeded the Canadian Market which returned 3.6% over the past year.
Price Volatility
| RAMM volatility | |
|---|---|
| RAMM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 14.2% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: RAMM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine RAMM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Jack Burnett | n/a |
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland. The company also engages in the resale of medical supplies products; and sale of medical devices and consumables, and veterinarian products. It offers Cosmetic CBD+CBG.
RAMM Pharma Corp. Fundamentals Summary
| RAMM fundamental statistics | |
|---|---|
| Market cap | CA$7.16m |
| Earnings (TTM) | -CA$8.35m |
| Revenue (TTM) | CA$4.69m |
1.7x
P/S Ratio-0.9x
P/E RatioIs RAMM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAMM income statement (TTM) | |
|---|---|
| Revenue | CA$4.69m |
| Cost of Revenue | CA$4.43m |
| Gross Profit | CA$265.64k |
| Other Expenses | CA$8.62m |
| Earnings | -CA$8.35m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.07 |
| Gross Margin | 5.66% |
| Net Profit Margin | -177.94% |
| Debt/Equity Ratio | 0% |
How did RAMM perform over the long term?
See historical performance and comparison